Local verification and calibration of the international sensitivity index (ISI) using certified plasmas can improve the accuracy of INR reporting for patients on vitamin K antagonists.
Answers are grounded in this paper and cite their sources.
Supports local ISI calibration for accurate INR in VKA patients; leaves open need for outcome trials before practice change.
The current method for monitoring vitamin K antagonist (AVK) anticoagulant therapy is the international normalized ratio (INR) that provides consistency and standardization for the prothrombin time (PT) assay value. Even after the standardization of the INR, inaccuracies of this value have still been reported. To make the INR even more accurate, better local assessments of INR parameters are becoming available. These new methods use plasmas with certified INR values to locally verify and, if necessary, recalculate the international sensitivity index (ISI) for the local laboratory’s reagent and instrument system. This CE Update will discuss the concepts of local verification and calibration to better define the manufacturer’s assigned ISI value, thus reporting more accurate INR results.
No takes yet. Share an insight, caveat, or question.
Marlar et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: